| scholarly article | Q13442814 |
| P2093 | author name string | Jecko Thachil | |
| P2860 | cites work | Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions | Q33341892 |
| Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases | Q33398134 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Remodeling the blood coagulation cascade | Q34294608 | ||
| Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology | Q34946830 | ||
| Screening for the risk for bleeding or thrombosis | Q35056709 | ||
| Role of coagulation testing in predicting bleeding risk | Q35606322 | ||
| Vitamin K nutrition, metabolism, and requirements: current concepts and future research | Q36828726 | ||
| How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults | Q36867591 | ||
| Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology | Q37084857 | ||
| Relevance of clotting tests in liver disease | Q37143012 | ||
| The coagulopathy of chronic liver disease | Q37900633 | ||
| Newer anticoagulants in critically ill patients | Q38020061 | ||
| Laboratory investigations for bleeding disorders | Q38046536 | ||
| Dabigatran: a cause of hematologic emergency | Q38065759 | ||
| HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD. | Q40924295 | ||
| A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin | Q43720788 | ||
| Routine pre-operative blood testing: is it necessary? | Q44110935 | ||
| Hemostasis and thrombosis in patients with liver disease: the ups and downs | Q44804623 | ||
| Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease | Q45145414 | ||
| Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma | Q45866854 | ||
| The partial thromboplastin time: defining an era in coagulation | Q45870318 | ||
| Armand J. Quick: pioneer and prophet of coagulation research. | Q52418951 | ||
| Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. | Q53116575 | ||
| Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. | Q55035657 | ||
| Rare bleeding disorders | Q61040497 | ||
| Safety of invasive procedures in patients with the coagulopathy of liver disease | Q69393026 | ||
| Disseminated intravascular coagulation. Findings in 346 patients | Q71513497 | ||
| Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity | Q79788208 | ||
| Anemia – The overlooked factor in bleeding related to liver disease | Q82506000 | ||
| Liver biopsy | Q83395480 | ||
| Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences | Q84073824 | ||
| Current concepts in the management of disseminated intravascular coagulation | Q84340569 | ||
| ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders | Q84564581 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 239-244 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Clinical Medicine | Q5133773 |
| P1476 | title | Dispelling myths about coagulation abnormalities in internal medicine | |
| P478 | volume | 14 |
Search more.